Hayden Royal’s Accendra Health ACH Stock Holding History

Hayden Royal’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-28,785	Closed	-$182K	–	183
2018 Q4	$182K	Buy	+28,785	New	+$299K	0.09%	188

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Hayden Royal's ACH Position: Q1 2019 in Review

Hayden Royal sold out of Accendra Health (ACH) in Q1 2019, closing a stake of 28,785 shares — an estimated $182K sold.

Hayden Royal first reported a position in ACH in Q4 2018 and held it in 1 quarter. The position peaked at $182K in Q4 2018. 187 funds tracked by Wall St. Rank hold ACH as of Q1 2019.

Hayden Royal reported no remaining Accendra Health position as of Q1 2019 after selling out during the quarter.
Hayden Royal sold 28,785 Accendra Health shares in Q1 2019, an estimated $182K.
Hayden Royal first reported a position in Accendra Health in Q4 2018 and held it in 1 quarter.
Hayden Royal's Accendra Health position peaked at $182K in Q4 2018.
187 funds tracked by Wall St. Rank held Accendra Health as of Q1 2019.

Based on Hayden Royal's 13F filing for Q1 2019, filed 8 Apr 2019.